The Marfan Foundation and The VEDS Movement, in collaboration with our Professional Advisory Board (PAB), continues to monitor the news regarding COVID-19 and wants to provide updated information for our community. We would like to reaffirm the recommendations issued by the Centers for Disease Control and Prevention (CDC) regarding the virus and want to add specific information for the Marfan, Vascular EDS, and LDS syndrome communities and those with other genetic aortic conditions.
On March 10, the CDC released new guidelines for people at risk of serious illness with the coronavirus. The Professional Advisory Board has further defined who in our population may indeed be more susceptible because not all people with Marfan, Vascular EDS (VEDS), and LDS are at equal risk due to individual variability.
The Foundation’s Professional Advisory Board asserts the following.
Who is at Higher Risk
People with genetic aortic conditions who also have significant lung disease should consider themselves at high risk and employ the highest protective strategies to try to prevent infection.
This group includes individuals with any of the following lung diagnoses:
- Restrictive lung disease
- Significant asthma (requiring chronic medications or hospitalization)
- Chronic obstructive pulmonary disease (COPD)
- Respiratory insufficiency
- Recurrent pneumothoraces
People with genetic aortic conditions are also at higher risk with COVID-19 if they have any of the following cardiovascular diagnoses:
- Significant valve regurgitation (causing symptoms or requiring medications)
- Heart failure
- Cardiac (ventricular) dysfunction (causing symptoms or requiring frequent monitoring or medications)
Selected patients with vascular connective tissue disorders can have additional associated conditions that could impose higher risk with COVID-19. These include:
- Chronic malnutrition
- Inflammatory bowel disease requiring use of immunosuppressants
- Other diseases requiring chronic use of steroids or other immunosuppressive drugs
People with genetic aortic conditions with none of the previously mentioned conditions whose cardiovascular features is an isolated aortic root dilation or aneurysm are not considered at higher risk than the general population.
You should discuss any other chronic conditions with your primary care doctor to determine if they might increase the risks associated with COVID-19.
People with genetic aortic conditions at higher risk, as explained above, are advised to get flu (influenza) and pneumonia (pneumococcal polysaccharide vaccine, PPSV, also known as known as Pneumovax 23, PPV-23) vaccines and to follow all the protective strategies outlined in the newly released CDC guidelines for patients with chronic illness.
The PAB suggests that people with genetic aortic conditions report symptoms to their primary care provider as soon as they experience them to assure prompt testing and immediate treatment.
Treatment for Flu, COVID-19, and other Potentially Severe Infectious Respiratory Illnesses
- Seek medical attention to get appropriate testing.
- If your physician thinks that your respiratory symptoms could be helped by antibiotics, do not take fluoroquinolones, a commonly prescribed class of antibiotics, if there are suitable alternatives or unless advised by an infectious disease specialist. These drugs should not be used in people with certain genetic conditions that are associated with aortic aneurysms and dissections such as VEDS, Marfan syndrome and other genetic aortic conditions. The antibiotics in this class are: Avelox, Cipro, Factive, Levaquin, and Ofloxacin.
- Choose a cold medication designed for people who have high blood pressure. Some cold medications do not contain decongestants. However, these medications may contain other powerful drugs, such as dextromethorphan, that can be dangerous if you take too much. Follow the dosing instructions carefully.
- Avoid over-the-counter decongestants and multi-symptom cold remedies that contain decongestants — such as pseudoephedrine, ephedrine, phenylephrine, naphazoline and oxymetazoline.
- Take a pain reliever such as acetaminophen to relieve a fever, sore throat, headache, or body aches.
- To relieve nasal congestion, try saline nasal spray. The spray can help flush your sinuses.
- Soothe your throat. To relieve a sore or scratchy throat, gargle with warm salt water or drink warm water with lemon juice and honey.
- Drink plenty of fluids. Water, juice, tea, and soup can help clear your lungs of phlegm and mucus.
- Increase the humidity in your home. Use a cool-mist humidifier or vaporizer to moisten the air, which may ease congestion and coughing.
- Get plenty of rest. If you are not feeling well, take it easy.
On Thursday, March 12, the Foundation hosted a webinar on this topic featuring three members of our Professional Advisory Board.
One thought on “New Statement Regarding COVID-19 and Genetic Aortic Conditions”
Comments are closed.